About

About

Successful companies rely on new products to keep them ahead of the competition, but developing and bringing them to market on time and on budget needs knowledge, competence and a proven track record.

What sets IDT apart is our ability to combine a cross-functional understanding of the challenges of drug development with the application of our world-class R&D, manufacturing and clinical trial facilities and processes to accomplish your project on time, within budget and to the highest global quality standards.

Whether it is API synthesis, finished dose product manufacturing, analytical testing, clinical packaging or a first in man clinical study, IDT can tailor a flexible and responsive approach to suit your individual project’s needs.

Challenge us with your current project.

Pic
Global Regulatory Compliance
When it comes to regulatory compliance, IDT has the world covered.
Audit History.
TGA Full GMP (Finished Product, API) on-site inspection September 2013
US FDA Full GMP (Finished Product, API) February 2013
TGA Full GMP (Finished Product, API) on-site inspection February 2011
TGA Full GMP (Finished Product, API) on-site inspection June 2009
USFDA Full GMP (Finished Product, API) on-site inspection May 2009
Health Labour and Welfare (Japan) (Non-sterile API) February 2009
TGA (Sterile Product Finished Product) on-site inspection July 2008
TGA Full GMP (Finished Product, API) on-site inspection July 2007
TGA Full GMP (Finished Product) on-site inspection August 2004
TGA Full GMP (Finished Product, API) on-site inspection March 2004
US FDA Full GMP (API) on-site inspection May 2001
GCP and GLP Audit of CMAX Feb 2000
R&D Tax CreditsAs IDT is a Registered Research Agency with the Australian Industry Research and Development Board, clients may be eligible for a 45 Cents in the Dollar Cash Rebate or a 40% Tax Shield on eligible R&D activities undertaken by IDT under the R&D Tax Incentive scheme. Contact us to find out more about accessing this scheme.